Know This Before Getting Your Bloodwork Done

In this health‑advice monologue, Dr. David Perlmutter explains why fasting insulin, rather than just blood glucose, is a crucial early indicator of metabolic dysfunction. He describes insulin’s normal role in lowering blood sugar and how, when cells become insulin‑resistant, the pancreas compensates by secreting more insulin. Elevated fasting insulin can appear long before glucose levels rise, making it a superior marker for pre‑diabetes. He provides target fasting insulin ranges (2–5 µIU/mL is optimal; 8–10 µIU/mL suggests insulin resistance) and links high insulin to heightened risk of type 2 diabetes, Alzheimer’s disease, coronary artery disease, and other conditions. Finally, he urges listeners to proactively ask their physicians to include a fasting insulin test on their next blood work panel, offering a brief script for the conversation.










